InflaRx NV (IFRX)
2.05
-0.05
(-2.38%)
USD |
NASDAQ |
Aug 24, 16:00
2.04
-0.01
(-0.49%)
After-Hours: 20:00
InflaRx Enterprise Value : 121.83M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 121.83M |
| August 21, 2026 | 129.20M |
| August 20, 2026 | 117.41M |
| August 19, 2026 | 132.14M |
| August 18, 2026 | 140.99M |
| August 17, 2026 | 124.78M |
| August 14, 2026 | 120.35M |
| August 13, 2026 | 115.93M |
| August 12, 2026 | 115.93M |
| August 11, 2026 | 114.46M |
| August 10, 2026 | 108.56M |
| August 07, 2026 | 90.88M |
| August 06, 2026 | 73.20M |
| August 05, 2026 | 80.56M |
| August 04, 2026 | 82.04M |
| August 03, 2026 | 77.62M |
| July 31, 2026 | 70.25M |
| July 30, 2026 | 73.20M |
| July 29, 2026 | 62.88M |
| July 28, 2026 | 68.78M |
| July 27, 2026 | 70.25M |
| July 24, 2026 | 76.14M |
| July 23, 2026 | 74.67M |
| July 22, 2026 | 84.99M |
| July 21, 2026 | 86.46M |
| Date | Value |
|---|---|
| July 20, 2026 | 87.93M |
| July 17, 2026 | 93.09M |
| July 16, 2026 | 101.20M |
| July 15, 2026 | 117.41M |
| July 14, 2026 | 115.93M |
| July 13, 2026 | 123.30M |
| July 10, 2026 | 121.83M |
| July 09, 2026 | 123.30M |
| July 08, 2026 | 138.04M |
| July 07, 2026 | 132.14M |
| July 06, 2026 | 130.67M |
| July 02, 2026 | 149.83M |
| July 01, 2026 | 163.09M |
| June 30, 2026 | 149.83M |
| June 29, 2026 | 119.92M |
| June 26, 2026 | 93.89M |
| June 25, 2026 | 89.55M |
| June 24, 2026 | 94.62M |
| June 23, 2026 | 94.62M |
| June 22, 2026 | 92.45M |
| June 18, 2026 | 85.94M |
| June 17, 2026 | 86.66M |
| June 16, 2026 | 70.76M |
| June 15, 2026 | 72.20M |
| June 12, 2026 | 70.76M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| MediGene AG | -- |
| BioNTech SE | 11.81B |
| Immatics NV | 754.82M |
| Beam Therapeutics, Inc. | 2.020B |
| Kymera Therapeutics, Inc. | 9.409B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.38M |
| Total Expenses (Quarterly) | 12.38M |
| EPS Diluted (Quarterly) | -0.1052 |
| Earnings Yield | -31.63% |
| Normalized Earnings Yield | -27.69 |